Asclera is a popular brand name for the medication polidocanol, commonly used as an FDA approved injectable agent for sclerotherapy of the lower extremities. Asclera is performed to treat spider or reticular veins which are slightly smaller than varicose veins. Often 2-4 treatments spaced 4-6 weeks apart are necessary for visual resolution of these types of veins. Patients with acute thromboembolic diseases should not receive injections with Asclera. Book your aesthetic consult today if you would like to determine whether or not you are a good candidate for Asclera and to discuss a treatment plan to get your legs visibly free from spider and reticular veins.